Company to focus on its core microplate instrumentation business, and sells biomedical division to Fluke Corporation
Bio-Tek divests biomedical division Company to focus on its core microplate instrumentation business, and sells biomedical division to Fluke Corporation.
Bio-Tek has recently divested its biomedical division to focus on its microplate instrumentation, software, and robotic systems, which serve the rapidly expanding biotechnology and drug discovery markets.
Fluke Corporation, a supplier of electrical test and measurement technology, has acquired the biomedical instruments division, which comprises three organisations: DNI Nevada, Dale Technologies, and the biomedical division of Bio-Tek Instruments.
According to Briar Alpert, president of Bio-Tek's parent Lionheart Technologies, "This strategic decision will allow for increased focus and investment in Bio-Tek instruments's laboratory dDivision." Alpert also reported that "the remarkable growth of our microplate business, over 20% in certain markets last year, encouraged us to focus our full attention on meeting the emerging requirements of this high-growth, competitive market.
We are increasingly being recognised as a market leader in all facets of the microplate instrument and data management market." Over the past 24 months, Bio-Tek has introduced the PowerWave HT microplate spectrophotometer, Fastrack robotic arm and stacker, µFill stand-alone microplate dispenser, and Precision 2000 automated 384-/96-well pipetting work station.
